dipropionate


Also found in: Wikipedia.

di·pro·pi·o·nate

 (dī′prō′pē-ə-nāt′)
n.
A derivative of an organic diol or polyalcohol that results from esterification involving two chemical equivalents of propionic acid.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
Mentioned in ?
References in periodicals archive ?
- The US Food and Drug Administration has expanded the approved indication for Enstilar (calcipotriene and betamethasone dipropionate) Foam, 0.005%/0.064%, for the topical treatment of plaque psoriasis to include patients age 12 and older, US-based medical dermatology company Leo Pharma Inc., a wholly owned subsidiary of Denmark-based Leo Pharma A/S, said.
For example, betamethasone dipropionate 0.05% in an ointment is considered a class I super potent steroid, whereas the same ingredient at the same concentration in a spray is a class III steroid.
One study showed that 7 of 10 (70%) of children taking maintenance doses of beclomethasone dipropionate had growth impairment after 6 months of therapy.
Mathias Tiedemann Svendsen, M.D., from Odense University Hospital in Denmark, and colleagues randomized 122 patients who were receiving once-daily medication (calcipotriol/betamethasone dipropionate [Cal/BD] cutaneous foam) to either no app (66 patients) or an app intervention (68 patients).
M2 EQUITYBITES-February 20, 2018-Teva Pharmaceutical in US launch of QVAR RediHaler (beclomethasone dipropionate HFA) Inhalation Aerosol
Topical calcipotriol/betamethasone dipropionate is a yellow-to-white substance including 50 [micro]g/g calcipotriol and 500 [micro]g/g betamethasone dipropionate.
In a study by Kumar et al., 5% crude coal tar ointment was shown to induce 75% reduction in erythema severity index (ESI) in 59% of patients at 12 weeks.[1] Betamethasone dipropionate is a relatively new topical agent and there are numerous studies to document its efficacy in psoriasis.
market introduction of its calcipotriene and betamethasone dipropionate ointment, the first generic version of Leo Pharma's Taclonex ointment.
Horses of group A, were treated with pentamidine methunsulphate at a dose rate of 3 mg/kg body weight intravenously, horses of group B were treated with imidocarb dipropionate at a dose rate of 2.4 mg/kg body weight intramuscularly, while horses of group C were treated with diminazene diaceturate at a dose rate of 3.5mg/kg bodyweight intramuscularly.